- Active not recruitingPHASE2
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
This study is testing a new medicine called MK-1167 for people with Alzheimer's disease. Researchers want to see if it can improve memory and thinking when taken with standard treatment and if it's safe and well-tolerated.
For: Alzheimer Disease · DementiaUnited States · Argentina · Canada - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia
This study is testing a new medicine, MK-1167, for people with mild to moderate Alzheimer's disease. Researchers want to see if it helps improve memory and thinking, and if it's safe to use. Some participants will receive the medicine, while others will get a dummy pill.
For: Alzheimer’s disease dementiaNetherlands · Italy · Spain